ENGEL expands market share amid global uncertainty

The globally operating ENGEL Group has closed the 2024/25 financial year with a turnover of approximately EUR 1.5 billion. Despite a continued decline in market conditions, the injection moulding machine manufacturer held its ground against European competitors and continued to expand its market share – driven by innovation and targeted regional strategies.

Although revenue fell by nearly 10% compared to the previous year, ENGEL has demonstrated its resilience. The past financial year was marked by reduced investment activity and a significant drop in incoming orders across all areas of industry. ENGEL not only remained stable in this environment, but also systematically increased its market share in multiple sectors and regions. "We have learnt to remain capable of action during crises - and once again proven that ENGEL can act reliably and with foresight even under difficult conditions," says Stefan Engleder, CEO ENGEL Group.

To address the global decline in demand, ENGEL is pursuing a triad strategy focused on Europe, the Americas and Asia. This approach is supported by independent hubs with sales, sales support, production and after sales – strengthening local presence and technological innovation.

Particularly in the areas of automation and service, the company has launched key initiatives to enhance customer proximity, delivery reliability, and solution orientation. "Especially in economically challenging times, the importance of a reliable service partner becomes clear. Our goal remains to ensure maximum system availability throughout the entire lifecycle," says Engleder.

While the automotive sector continues to face structural uncertainties, interest is growing in solutions for lightweight construction and alternative materials. In technical injection moulding, ENGEL was able to strengthen its market position through expertise in applications technology, despite the overall market trend. The Packaging division proved to be much more resilient, benefiting from an increase in demand. The Medical division remained stable, with sustained interest in specific applications such as auto-injectors helping to offset a slight overall decline.

International apprentice training remains a cornerstone of ENGEL’s personnel development efforts. Worldwide, a total of 397 apprentices are currently completing their training at ENGEL, including 227 in Austria. In today’s competitive labour market, developing young talent remains a key pillar of the long-term personnel strategy.

"We are making targeted investments in the next generation of skilled professionals – offering hands-on training and international development opportunities. This enables us to maintain our ability to innovate well into the future," says Engleder.